Recruiting Alpha-1 Antitrypsin Deficiency Studies in Gainesville
About Alpha-1 Antitrypsin Deficiency Clinical Trials in Gainesville
Alpha-1 antitrypsin deficiency is a genetic condition that increases the risk of lung and liver disease due to low levels of the protective protein alpha-1 antitrypsin. It is one of the most common genetic causes of COPD. Treatment includes augmentation therapy and management of lung and liver symptoms.
There are currently 3 alpha-1 antitrypsin deficiency clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 50,380 participants. Research is being sponsored by University of Florida, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alpha-1 Antitrypsin Deficiency Clinical Trials in Gainesville — FAQ
Are there alpha-1 antitrypsin deficiency clinical trials in Gainesville?
Yes, there are 3 alpha-1 antitrypsin deficiency clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gainesville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.
Are clinical trials in Gainesville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.
What alpha-1 antitrypsin deficiency treatments are being tested?
The 3 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for alpha-1 antitrypsin deficiency.
Data updated October 15, 2026 from ClinicalTrials.gov